Platelet granule biogenesis in health and disease

描述（由申请人提供）：活化的血小板分泌一系列可溶性介质，这些介质在适当的血凝块形成、炎症、血管生成和其他生理反应中起关键作用。在静息血小板中，大多数介质储存在至少两种不同类型的分泌颗粒中：蛋白质介质如纤维蛋白原和血管性血液病因子储存在1颗粒中，而ADP、ATP、钙和5 -羟色胺储存在致密颗粒中。这些颗粒在巨核细胞内产生，并被隔离成血小板。这两种类型的颗粒被认为与溶酶体有一些共同的特征，但它们是如何形成的，以及它们的内容物是如何与巨核细胞内传统的溶酶体内容物特异性分离的尚不清楚。任何一类颗粒的形成缺陷，或其中特定成分的储存缺陷，都会导致出血时间延长和血小板异常聚集。特别是，Hermansky-Pudlak综合征（HPS）患者的致密颗粒和组织特异性溶酶体相关细胞器，包括色素细胞中的黑素小体，在至少8种基因突变的一组疾病中都是畸形的。我们在了解几种hps相关基因的产物如何在蛋白质从内体转运到黑素小体的过程中发挥作用方面取得了相当大的进展，并表征了与这些基因产物相互作用的细胞质分选信号，并介导了整体膜蛋白特异性地分选到黑素小体。在本提案中，我们将利用我们对黑素细胞的知识，两种独特的巨核细胞培养系统的可用性，以及最近发现的致密颗粒上的完整膜蛋白来验证类似的途径调节黑素细胞中黑色素小体和巨核细胞中致密颗粒的蛋白质分选，并且这些途径与调节蛋白质分选到1颗粒的途径不同的假设。我们还将测试假设，适当的靶向蛋白质特异性致密颗粒需要hps相关的基因产物。我们的具体目标是：1；检测致密颗粒蛋白是否定位于黑素细胞内的黑素小体，以及黑素小体蛋白是否定位于巨核细胞内的致密颗粒。2. 测试细胞质靶向信号（如黑素体蛋白上的信号）是否必要和/或充分地将SLC35D3靶向致密颗粒或其前体。3. 在缺乏不同hps相关基因产物的巨核细胞中，检测致密颗粒蛋白是否在核内体中存在差异错定位。

DESCRIPTION (provided by applicant): Activated platelets secrete a host of soluble mediators that play critical roles in proper blood clot formation, inflammation, angiogenesis, and other physiological responses. In resting platelets, most of these mediators are stored within at least two distinct classes of secretory granules: protein mediators such as fibrinogen and von Willebrand factor are stored in 1 granules, whereas ADP, ATP, calcium and serotonin are stored in dense granules. These granules are generated within megakaryocytes and sequestered into forming platelets. Both types of granules are thought to share some features with lysosomes, but how they are formed and how their contents are specifically segregated from traditional lysosomal contents within megakaryocytes is not known. Defects in the formation of either class of granule, or in the storage of specific components within them, result in prolonged bleeding and abnormal platelet aggregation. In particular, dense granules and tissue-specific lysosome-related organelles in several other cell types, including melanosomes in pigment cells, are malformed in patients with Hermansky-Pudlak Syndrome (HPS), a group of disorders with mutations in any of at least eight genes. We have made considerable progress in understanding how the products of several HPS-associated genes function in trafficking of proteins from endosomes to melanosomes, and have characterized cytoplasmic sorting signals that interact with some of these gene products and mediate sorting of integral membrane proteins specifically to melanosomes. In this proposal, we will exploit our knowledge of the melanocyte, the availability of two unique megakaryocyte culture systems, and a recently discovered integral membrane protein on dense granules to test the hypothesis that similar pathways regulate protein sorting to melanosomes in melanocytes and to dense granules in megakaryocytes, and that these pathways are distinct from those that regulate protein sorting to 1 granules. We will also test the hypothesis that proper targeting of proteins specifically to dense granules requires HPS-associated gene products. Our Specific Aims are: 1. To test whether dense granule proteins localize to melanosomes in melanocytes and whether melanosomal proteins localize to dense granules in megakaryocytes. 2. To test whether cytoplasmic targeting signals like those on melanosomal proteins are necessary and/or sufficient to target SLC35D3 to dense granules or their precursors. 3. To test whether dense granule proteins are differentially mislocalized to endosomes in megakaryocytes that lack different HPS-associated gene products. PUBLIC HEALTH RELEVANCE: In order for blood clots to form during tissue damage, platelets must be activated to release a number of components from specialized granules called 1 and dense granules. Formation of these granules is a clinically important process because their malformation underlies a number of genetic and acquired bleeding disorders, but very little is known about how they form and accumulate their contents. In this project, we will exploit our understanding of the formation of a different but related organelle in pigment cells to determine how the platelet granules are formed and what goes wrong in certain heritable bleeding disorders.